FABRAZYME/ФАБРАЗИМ 35 MG 1 FLK. (аgalsidase beta/агалсидаза бета) Genzyme Ireland

New
Product Code: 76
0
In stock 5
91,805.00 грн.

Description of the drug

Fabrazyme is a medicinal product that contains agalsidase beta. It is used to treat patients with certain genetic disorders. The drug is supplied in a vial form by the manufacturer Genzyme Ireland.

Indications for use

Fabrazyme is prescribed for the treatment of patients with certain genetic disorders who require additional supportive treatment.

Advantages


    Effectiveness in treating genetic disorders
  • Support for the patient's body
  • Convenient form of release

Application

The drug is taken according to the doctor's recommendations. The frequency and dosage are determined by the specialist who prescribed the drug.

Who is suitable

Fabrazyme is suitable for patients with certain genetic disorders who require supportive treatment.

Search queries

This drug is also searched for as: agalsidase beta, support drugs, Fabrazyme 35 mg.

Characteristics
Chemical name агалсидаза бета
Commercial name Фабразим
Dosage 35
Number 1
Release form Флакон
Write a review
Note: HTML is not translated!